Related Experiment Video
Updated: Apr 10, 2026
06:16
Author Spotlight: Advancing Thrombolytic Testing by Integrating Flow Dynamics in In Vitro Models
Published on: April 19, 2024
2.1K
Fibrinogen and catheter-directed thrombolysis
1Division of Vascular Surgery and Endovascular Therapy, University of Florida College of Medicine, P.O. Box 100128, 1600 SW Archer Road, Suite NG-45, Gainesville, FL 32610-0128.
Seminars in Vascular Surgery
|June 16, 2015
Summary
Fibrinogen, a key glycoprotein, is crucial for blood clot formation and atherosclerosis. Its role in human physiology makes it a valuable biomarker for cardiovascular diseases and thrombosis treatment.
Area of Science:
- Biochemistry
- Physiology
- Pathophysiology
Background:
- Fibrinogen is a complex glycoprotein.
- It plays a significant role in thrombus formation and evolution.
- Fibrinogen is linked to the pathophysiology of atherosclerosis.
Purpose of the Study:
- To describe the expansive role that fibrinogen plays in human physiology.
- To highlight fibrinogen's importance as a biomarker for atherosclerotic disease.
- To discuss fibrinogen's utility as a marker during treatment for venous and arterial thrombosis.
Main Methods:
- Literature review of fibrinogen's physiological roles.
- Analysis of studies evaluating fibrinogen as a biomarker.
- Synthesis of evidence linking fibrinogen to thrombosis and atherosclerosis.
Main Results:
- Fibrinogen is integral to the coagulation cascade and clot stabilization.
- Elevated fibrinogen levels are associated with increased risk of atherosclerotic events.
- Fibrinogen serves as a predictive marker for thrombotic events and a monitoring tool for anticoagulant therapy.
Conclusions:
- Fibrinogen is a multifaceted protein with critical roles in hemostasis and vascular disease.
- Understanding fibrinogen's physiology is essential for its application as a clinical biomarker.
- Fibrinogen represents a significant target for therapeutic interventions in cardiovascular and thrombotic disorders.
Related Concept Videos
01:29Venous Thrombosis III: Interprofessional Care
469
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
469
01:16Clot Retraction and Fibrinolysis
10.4K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
10.4K
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
2.5K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.5K
01:29Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
680
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
680
01:18Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
2.8K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
2.8K
01:20Extrinsic and Intrinsic Pathways of Hemostasis
15.7K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
15.7K